Patent · US Active

Substituted imidazo[1,2-a]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus infections

US9163029B2 · kind B2 · utility

0Cited by
22References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 23, 2013
Grant dateOct 20, 2015
Priority date
Expiry dateOct 23, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D405/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula (I)its salts, isomers or prodrugs thereof useful in the treatment of viral infections, in particular respiratory syncytial virus (RSV) infections. The present invention also relates to processes for preparing the compounds and intermediates used in their preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.